Paula L. Kosasih - Concepedia

Concepedia

Author

Paula L. Kosasih

University of Washington

Also Known As

P L Kosasih, Paula Kosasih, Paula L. Kosasih, Prisca Kosasih

71

Publications

2.4K

Citations

7

H-Index

11

Concepts

All Affiliations

University of Washington Fred Hutch Cancer Center Institute for Advanced Study Scripps Research Institute Technical University of Munich

PL

About

Paula L. Kosasih is an author at University of Washington specializing in immunotherapy, autoimmune disease, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	884
2	Immunology	2	2	884
3	Autoimmune Disease	2	2	884
4	Allergy	1	1	62
5	Cell Biology	1	1	822

Paula L. Kosasih

×

7

Publications

2.4K

Citations

7

H-Index

	Year	Citations
Chimeric antigen receptor-modified T cells derived from defined CD8+ and CD4+ subsets confer superior antitumor reactivity in vivo Daniel Sommermeyer, Michael Hudecek, Paula L. Kosasih, Leukemia Superior Antitumor ReactivityTumor ImmunologyCancer ImmunosurveillanceAutoimmune DiseaseMedicine	2015	822
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells Michael Hudecek, Maria Teresa Lupo Stanghellini, Paula L. Kosasih, Clinical Cancer Research	2013	529
The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for <i>In Vivo</i> Antitumor Activity Michael Hudecek, Daniel Sommermeyer, Paula L. Kosasih, Cancer Immunology Research	2014	510
Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues Ashwini Balakrishnan, Tracy Goodpaster, Julie Randolph‐Habecker, Clinical Cancer Research	2016	204
Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor–Modified T Cells Carolina Berger, Daniel Sommermeyer, Michael Hudecek, Cancer Immunology Research	2014	171
Inclusion of Strep-tag II in design of antigen receptors for T-cell immunotherapy Lingfeng Liu, Daniel Sommermeyer, Alexandra Cabanov, Nature Biotechnology Strep-tag IiAllergyAutoimmune DiseaseT-cell ImmunotherapyT-regulatory Cell	2016	62
Multispecific Targeting with Synthetic Ankyrin Repeat Motif Chimeric Antigen Receptors Ashwini Balakrishnan, Anusha Rajan, Alexander I. Salter, Clinical Cancer Research	2019	55

Page 1